Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab. Academic Article uri icon

Overview

publication date

  • June 12, 2023

Identity

Scopus Document Identifier

  • 85161815845

Digital Object Identifier (DOI)

  • 10.1080/10428194.2023.2221756

PubMed ID

  • 37309201